Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.14% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRO
1201
DELISTED
Marathon Oil Corporation
MRO
| $11.4M | 0.01% |
959,446
-639,000
| -40% | -$8.94M |
|
1202
Artesian Resources
ARTNA
$355M
| $11.4M | 0.01% |
301,700
+19,000
| +7% | +$712K |
|
1203
HubSpot
HUBS
$11.4B
| $11.3M | 0.01% |
172,557
+77,657
| +82% | +$5.24M |
|
|
IXYS
1204
DELISTED
IXYS Corp
IXYS
| $11.3M | 0.01% |
688,772
+317,500
| +86% | +$4.74M |
|
1205
Enovis
ENOV
$1.63B
| $11.3M | 0.01% |
167,038
+80,759
| +94% | +$5.51M |
|
1206
Marcus Corp
MCS
$752M
| $11.3M | 0.01% |
374,416
+68,016
| +22% | +$2.2M |
|
1207
Voya Financial
VOYA
$8.98B
| $11.3M | 0.01% |
306,300
-184,500
| -38% | -$6.71M |
|
1208
EPR Properties
EPR
$4.85B
| $11.3M | 0.01% |
157,200
+100,900
| +179% | +$7.35M |
|
1209
Plains GP Holdings
PAGP
$5.16B
| $11.3M | 0.01% |
430,461
-257,100
| -37% | -$7.18M |
|
|
BRG
1210
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $11.2M | 0.01% |
872,256
+135,556
| +18% | +$1.72M |
|
|
OMN
1211
DELISTED
OMNOVA Solutions Inc.
OMN
| $11.2M | 0.01% |
1,150,175
+25,100
| +2% | +$227K |
|
1212
Qualcomm
QCOM
$179B
| $11.2M | 0.01% |
+202,560
| New | +$11.3M |
|
|
GV
1213
DELISTED
Goldfield Corporation
GV
| $11.2M | 0.01% |
2,030,899
+90,900
| +5% | +$446K |
|
|
FITB
1214
Fifth Third Bancorp
FITB
$51.7B
| $11.2M | 0.01% |
+430,026
| New | +$10.6M |
|
|
TEN
1215
Tsakos Energy Navigation Ltd
TEN
$1.18B
| $11.2M | 0.01% |
465,080
-5,960
| -1% | -$136K |
|
|
ATRS
1216
DELISTED
Antares Pharma, Inc.
ATRS
| $11.1M | 0.01% |
3,462,469
+309,900
| +10% | +$878K |
|
1217
ASE Group
ASX
$80.2B
| $11.1M | 0.01% |
1,757,179
-274,600
| -14% | -$1.72M |
|
|
AEGN
1218
DELISTED
Aegion Corp
AEGN
| $11.1M | 0.01% |
506,396
-53,700
| -10% | -$1.13M |
|
1219
Ribbon Communications
RBBN
$359M
| $11.1M | 0.01% |
1,488,000
-115,900
| -7% | -$854K |
|
|
OAK
1220
DELISTED
OAKTREE CAPITAL GROUP, LLC
OAK
| $11.1M | 0.01% |
237,370
+90,786
| +62% | +$4.2M |
|
1221
UMB Financial
UMBF
$10.7B
| $11M | 0.01% |
147,600
+2,700
| +2% | +$198K |
|
|
SC
1222
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $11M | 0.01% |
+865,600
| New | +$10.5M |
|
1223
Sumitomo Mitsui Financial
SMFG
$167B
| $11M | 0.01% |
1,404,339
+653,935
| +87% | +$4.86M |
|
|
CKH
1224
DELISTED
Seacor Holdings Inc.
CKH
| $11M | 0.01% |
332,121
+58,214
| +21% | +$3.08M |
|
|
PRGX
1225
DELISTED
PRGX Global, Inc.
PRGX
| $11M | 0.01% |
1,692,077
+24,267
| +1% | +$156K |
|
Similar funds
Renaissance Technologies's Q2 2017 Portfolio in Review
As of Q2 2017, Renaissance Technologies held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Renaissance Technologies deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Renaissance Technologies's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Renaissance Technologies's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Renaissance Technologies fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Renaissance Technologies's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Renaissance Technologies opened 398 new positions and closed 418 in Q2 2017.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.